Joshua Rottner

Cooley advised IN8Bio on its $40 million initial public offering of 4,000,000 shares of common stock. IN8Bio, whose securities now trade on the Nasdaq Global Market under the symbol INAB, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T-cell therapies. Partners Josh Kaufman, Jaime Chase and Josh Rottner led the Cooley team.

Cooley advised Jive Communications, a leading provider of cloud-based phone systems and unified communications services, on its agreement to sell to LogMeIn. Partners Miguel Vega and Joshua Rottner led the team advising Jive on the transaction.

Palo Alto – February 22, 2017 – Cooley advised Neurala – the software company that has invented The Neurala Brain, a deep learning neural networks platform that is making smart products like toys, cameras and self-driving cars more autonomous, interactive and useful – on its $14 million Series A financing.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Cooley advised Tarveda Therapeutics on its $30 million Series D financing round. New investor Versant Ventures led the round, which also included existing investors New Enterprise Associates, Novo A/S, NanoDimension and Flagship Pioneering.

Cooley advised Dyn on its sale to Oracle. Dyn, based in Manchester, New Hampshire, is the leading cloud-based Internet Performance and DNS provider.